PF 885706

Drug Profile

PF 885706

Alternative Names: PF-00885706; PF-885706

Latest Information Update: 10 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Pfizer
  • Class Benzimidazoles; Cyclobutanes; Digestion aids; Piperidines
  • Mechanism of Action Serotonin 4 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Gastro-oesophageal reflux

Most Recent Events

  • 22 Oct 2008 Pharmacodynamics data from a phase I trial in healthy volunteers for Gastro-oesophageal reflux presented at the 16th United European Gastroenterology Week (UEGW-2008)
  • 17 Jan 2007 Phase-I clinical trials in Gastro-oesophageal reflux in United Kingdom (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top